Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
Published: 2026-04-11
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
Originally sourced from cnbc